Skip to main content
See every side of every news story
Published loading...Updated

J&J exits Linx esophageal reflux business in some countries

Summary by medtechdive.com
Johnson & Johnson, which said it made the decision based on a market assessment, did not specify the markets it is leaving or provide a timeline.

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

medtechdive.com broke the news in on Tuesday, September 23, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal